Peritoneal carcinomatosis of colorectal origin Is there a role for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
S Zerhouni, J Andrea McCart - Oncology exchange, 2012 - search.ebscohost.com
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin carries a dismal prognosis,
as evidenced by a 5-year survival of less than 15% in patients treated with systemic …
as evidenced by a 5-year survival of less than 15% in patients treated with systemic …
Prospective quality of life study for colorectal cancer patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal …
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) is becoming accepted treatment for peritoneal carcinomatosis (PC) from colorectal …
(HIPEC) is becoming accepted treatment for peritoneal carcinomatosis (PC) from colorectal …
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience
LH Iversen, PC Rasmussen… - Colorectal …, 2013 - Wiley Online Library
Aim Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy
(HIPEC) is a treatment option with curative intent for selected patients with peritoneal …
(HIPEC) is a treatment option with curative intent for selected patients with peritoneal …
[HTML][HTML] Cytoreductive surgery versus systemic chemotherapy alone in isolated peritoneal carcinomatosis of colorectal origin
Objective: To compare the overall survival and progression-free survival of front-line
cytoreductive surgery (CRs)±hyperthermic intraperitoneal chemotherapy versus intensive …
cytoreductive surgery (CRs)±hyperthermic intraperitoneal chemotherapy versus intensive …
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis
BACKGROUND: Survival benefit of cytoreductive surgery combined with hyperthermic
intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for …
intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for …
[HTML][HTML] Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
C Paasch, G De Santo, HN Gamal-Eldin… - Annals of Medicine and …, 2021 - Elsevier
Introduction The prognosis of abdominal cancer with peritoneal carcinomatosis (PC) is poor.
In literature, some authors described a repeated Cytoreductive Surgery (CRS) with …
In literature, some authors described a repeated Cytoreductive Surgery (CRS) with …
Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study
Background The main prognostic factors after complete cytoreductive surgery (CCRS) of
colorectal peritoneal carcinomatosis (PC) followed by intraperitoneal chemotherapy (IPC) …
colorectal peritoneal carcinomatosis (PC) followed by intraperitoneal chemotherapy (IPC) …
Short-term complications in elderly patients undergoing CRS and HIPEC: a single center's initial experience
A Oemrawsingh, NL de Boer… - European Journal of …, 2019 - Elsevier
Introduction Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) is a well-established curative treatment for patients with peritoneal carcinomatosis …
(HIPEC) is a well-established curative treatment for patients with peritoneal carcinomatosis …
[HTML][HTML] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
N Vassos, T Förtsch, A Aladashvili… - World Journal of …, 2016 - Springer
Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy
(HIPEC) has become the treatment of choice for resectable peritoneal carcinomatosis (PC) …
(HIPEC) has become the treatment of choice for resectable peritoneal carcinomatosis (PC) …
Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal …
W Ceelen, Y Van Nieuwenhove, DV Putte… - Annals of surgical …, 2014 - Springer
Background In selected patients with colorectal peritoneal carcinomatosis (PC),
cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemoperfusion (HIPEC) may …
cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemoperfusion (HIPEC) may …